Skip to content

DAY ONE BIOPHARMACEUTICALS, INC.

CIK 0001845337

← back to feed
Revenue (TTM)
$198.23M
+20.6% YoY FY Apr 2026
Net Income (TTM)
−$49.01M
−12.4% YoY FY Apr 2026
EPS Diluted (TTM)
−$0.45
−2.0% YoY FY Apr 2026
Gross Margin
—
FY Apr 2026
Operating Margin
-35.6%
FY Apr 2026
Net Margin
-24.7%
FY Apr 2026
Free Cash Flow (TTM)
−$156.63M
FY Apr 2026
Cash
$197.08M
FY Apr 2026
Total Debt
—
FY Apr 2026
Shares Outstanding
103.33M sh
FY Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings